Vicious circle: Systemic autoreactivity in Ro52/TRIM21-deficient mice

Journal of Experimental Medicine

Volumn 206, Issue 8, 2009, Pages 1647-1651

  Bolland, Silvia ^a   Garcia Sastre, Adolfo ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INTERFERON; INTERLEUKIN 23;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; RIBONUCLEOPROTEINS;

EID: 68149156009     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091507     Document Type: Article

References (50)

1. Baechler, E.C., F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA. 100:2610-2615.
2. Baechler, E.C., P.K. Gregersen, and T.W. Behrens. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16:801-807.
3. Bennett, L., A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-723.
4. Blanco, P., A.K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 294:1540-1543
5. Chelbi-Alix, M.K., F. Quignon, L. Pelicano, M.H. Koken, and H. de Thé. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72:1043-1051.
6. Crispín, J.C., M. Oukka, G. Bayliss, R.A. Cohen, C.A. Van Beek, I.E. Stillman, V.C. Kyttaris, Y.T. Juang, and G.C. Tsokos. 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181:8761-8766.
7. Crow, M.K. 2007. Type I interferon in systemic lupus erythematosus. Curr. Top. Microbiol. Immunol. 316:359-386.
8. Crow, Y.J., A. Leitch, B.E. Hayward, A. Garner, R. Parmar, E. Griffith, M. Ali, C. Semple, J. Aicardi, R. Babul-Hirji, et al. 2006. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat. Genet. 38:910-916.
9. Deshmukh, U.S., H. Bagavant, J. Lewis, F. Gaskin, and S.M. Fu. 2005. Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin. Immunol. 117:112-120.
10. Doreau, A., A. Belot, J. Bastid, B. Riche, M.C. Trescol-Biemont, B. Ranchin, N. Fabien, P. Cochat, C. Pouteil-Noble, P. Trolliet, et al. 2009. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10:778-785.
11. Espinosa, A., V. Dardalhon, S. Brauner, A. Ambrosi, R. Higgs, F.J. Quintana, M. Sjöstrand, M.-L. Eloranta, J. Ní Gabhann, O. Winqvist, et al. 2009. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 206:1661-1671.
12. Gack, M.U., Y.C. Shin, C.H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J.U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 446:916-920.
13. Garrett-Sinha, L.A., S. John, and S.L. Gaffen. 2008. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr. Opin. Rheumatol. 20:519-525.
14. Higgs, R., J. Ní Gabhann, N. Ben Larbi, E.P. Breen, K.A. Fitzgerald, and C.A. Jefferies. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin- mediated degradation of IRF3. J. Immunol. 181:1780-1786.
15. Hsu, H.C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A.L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9:166-175.
16. Hueber, W., D. Zeng, S. Strober, and P.J. Utz. 2004. Interferon-alpha- inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum. 50:3239-3249.
17. Kälkner, K.M., L. Rönnblom, A.K. Karlsson Parra, M. Bengtsson, Y. Olsson, and K. Oberg. 1998. Antibodies against doublestranded DNA and development of polymyositis during treatment with interferon. QJM. 91:393-399.
18. Kelly, K.M., H. Zhuang, D.C. Nacionales, P.O. Scumpia, R. Lyons, J. Akaogi, P. Lee, B. Williams, M. Yamamoto, S. Akira, et al. 2006. "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum. 54:1557-1567.
19. Koenig, M., M. Dieudé, and J.L. Senécal. 2008. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun. Rev. 7:588-593.
20. Kong, H.J., D.E. Anderson, C.H. Lee, M.K. Jang, T. Tamura, P. Tailor, H.K. Cho, J. Cheong, H. Xiong, H.C. Morse III, and K. Ozato. 2007. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179:26-30.
21. Kozyrev, S.V., and M.E. Alarcon-Riquelme. 2007. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity. 40:591-601.
22. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D.F. Tough. 2001. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 14:461-470.
23. + Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:1589-1602.
24. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-530.
25. Marshak-Rothstein, A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6:823-835.
26. Mathian, A., A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov. 2005. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J. Immunol. 174:2499-2506.
27. Nakken, B., R. Jonsson, and A.I. Bolstad. 2001. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum. 44:638-646.
28. Ozato, K., D.M. Shin, T.H. Chang, and H.C. Morse III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
29. Rhodes, D.A., G. Ihrke, A.T. Reinicke, G. Malcherek, M. Towey, D.A. Isenberg, and J. Trowsdale. 2002. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures. Immunology. 106:246-256.
30. Rice, G., W.G. Newman, J. Dean, T. Patrick, R. Parmar, K. Flintoff, P. Robins, S. Harvey, T. Hollis, A. O'Hara, et al. 2007. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 80:811-815.
31. Rice, G.I., J. Bond, A. Asipu, R.L. Brunette, I.W. Manfield, I.M. Carr, J.C. Fuller, R.M. Jackson, T. Lamb, T.A. Briggs, et al. 2009. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41:829-832.
32. Roberts, T.L., A. Idris, J.A. Dunn, G.M. Kelly, C.M. Burnton, S. Hodgson, L.L. Hardy, V. Garceau, M.J. Sweet, I.L. Ross, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 323:1057-1060.
33. Routsias, J.G., and A.G. Tzioufas. 2007. Sjögren's syndrome - study of autoantigens and autoantibodies. Clin. Rev. Allergy Immunol. 32:238-251.
34. Rozzo, S.J., J.D. Allard, D. Choubey, T.J. Vyse, S. Izui, G. Peltz, and B.L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 15:435-443.
35. Sawalha, A.H., and J.B. Harley. 2004. Antinuclear autoantibodies in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16:534-540.
36. Sayah, D.M., E. Sokolskaja, L. Berthoux, and J. Luban. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 430:569-573.
37. Schulte-Pelkum, J., M. Fritzler, and M. Mahler. 2009. Latest update on the Ro/SS-A autoantibody system. Autoimmun. Rev. 8:632-637.
38. Shaw, M.H., V. Boyartchuk, S. Wong, M. Karaghiosoff, J. Ragimbeau, S. Pellegrini, M. Muller, W.F. Dietrich, and G.S. Yap. 2003. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10. Q/J mice to infection and autoimmunity. Proc. Natl. Acad. Sci. USA. 100:11594-11599.
39. Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, et al. 2008. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9:369-377.
40. Sigurdsson, S., G. Nordmark, H.H. Göring, K. Lindroos, A.C. Wiman, G. Sturfelt, A. Jönsen, S. Rantapää-Dahlqvist, B. Möller, J. Kere, et al. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76:528-537.
41. Stein, A.J., G. Fuchs, C. Fu, S.L. Wolin, and K.M. Reinisch. 2005. Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity. Cell. 121:529-539.
42. Stetson, D.B., J.S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 134:587-598.
43. Strandberg, L., A. Ambrosi, A. Espinosa, L. Ottosson, M.L. Eloranta, W. Zhou, A. Elfving, E. Greenfield, V.K. Kuchroo, and M. Wahren-Herlenius. 2008. Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J. Clin. Immunol. 28:220-231.
44. Stremlau, M., C.M. Owens, M.J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427:848-853.
45. Tailor, P., T. Tamura, and K. Ozato. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16:134-140.
46. Thibault, D.L., A.D. Chu, K.L. Graham, I. Balboni, L.Y. Lee, C. Kohlmoos, A. Landrigan, J.P. Higgins, R. Tibshirani, and P.J. Utz. 2008. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 118:1417-1426.
47. Wong, C.K., L.C. Lit, L.S. Tam, E.K. Li, P.T. Wong, and C.W. Lam. 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127:385-393.
48. Xue, D., H. Shi, J.D. Smith, X. Chen, D.A. Noe, T. Cedervall, D.D. Yang, E. Eynon, D.E. Brash, M. Kashgarian, et al. 2003. A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc. Natl. Acad. Sci. USA. 100:7503-7508.
49. Yoshimi, R., T.H. Chang, H. Wang, T. Atsumi, H.C. Morse III, and K. Ozato. 2009. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 182:7527-7538.
50. Zhuang, H., S. Narain, E. Sobel, P.Y. Lee, D.C. Nacionales, K.M. Kelly, H.B. Richards, M. Segal, C. Stewart, M. Satoh, and W.H. Reeves. 2005. Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin. Immunol. 117:238-250.